Shih, Alan H. External Entity

Publications

Sort by

Selected publications

  • CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.  Cancer cell2015 Academic Article GET IT
    Times cited: 21

Other